EUVIMEDEUVIMED entdecken
Crossref

Human Umbilical Cord Mesenchymal Stem Cells Alleviate Autoimmune POI Associated With Downregulated UBE2N ‐Mediated Ovarian Inflammation

Jinwei Li iD, Xianghui Wen iD, Jiaoshi Zhao iD, Min Gao, Xubin Hao iD, Shenghui Wen, Liuzhong Zhou, Xinyu Wu, Xiqing Luo iD, Shuangyan Cao, Qiujing Wei, Budian Liu und 3 weitere

International Journal of Rheumatic Diseases · 2026

DOI: 10.1111/1756-185x.70822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Jinwei Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Huishan Biotechnology co., Ltd., Shenzhen, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Ubiquitin-Conjugating Enzymes, Ovary, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 29 Literaturangaben. Gefördert von: the Shenzhen Longhua District Science and Technology Innovation Special Fund Project, the Shenzhen Longhua District Science and Technology Innovation Special Fund Project, Digital Immunity Project, the Autonomous Region Key Research and Development (Major) Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the therapeutic efficacy of human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs) in a murine model of autoimmune premature ovarian insufficiency (POI), and to investigate the association between ubiquitin‐conjugating enzyme E2N (UBE2N) expression and disease progression as well as treatment response.

Methods

Autoimmune POI was induced in female BALB/c mice by zona pellucida glycoprotein 3 peptide (pZP3) immunization. Thirty mice were randomly assigned to Control, POI Model, and hUC‐MSC Treatment groups. Treated mice received weekly tail vein injections of hUC‐MSCs (1 × 10 6 cells/mouse) for 4 weeks. Estrous cyclicity, fertility, ovarian histopathology, peripheral Th17/Treg balance, and the expression of IL‐17, IFN‐γ, and UBE2N were evaluated by immunohistochemistry.

Results

Compared with the POI Model group, hUC‐MSC treatment restored regular estrous cyclicity, improved ovarian morphology, and increased litter size. Flow cytometry showed correction of the abnormal Th17/Treg imbalance in treated mice. Immunohistochemistry revealed marked upregulation of UBE2N, IL‐17, and IFN‐γ in ovarian tissue from POI mice, whereas hUC‐MSC administration significantly reduced their expression. No treatment‐related adverse effects were observed. Conclusion hUC‐MSCs effectively alleviated ovarian dysfunction in autoimmune POI mice. The therapeutic improvement was accompanied by systemic immune rebalancing and decreased aberrant ovarian UBE2N expression, indicating UBE2N as a candidate inflammatory biomarker associated with autoimmune ovarian injury and immune dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyUbiquitin-Conjugating EnzymesOvaryMesenchymal Stem Cell TransplantationAutoimmune DiseasesUmbilical CordCord Blood Stem Cell TransplantationOophoritisFemaleAnimalsDisease Models, AnimalMice, Inbred BALB CHumansT-Lymphocytes, RegulatoryTh17 CellsInterleukin-17Interferon-gammaDown-RegulationInflammation MediatorsFertilityEstrous CycleZona Pellucida GlycoproteinsCells, Cultured

Stichwörter der Autor:innen

Th17/Treg balanceUBE2Nautoimmune ovarian injuryhuman umbilical cord‐derived mesenchymal stem cellsovarian inflammationpremature ovarian insufficiency

Substanzen

Ubiquitin-Conjugating EnzymesInterleukin-17Interferon-gammaInflammation MediatorsZp3 protein, mouseZona Pellucida GlycoproteinsIl17a protein, mouseIFNG protein, mouse

Autor:innen und Institutionen

  • Shenzhen Huishan Biotechnology co., Ltd., Shenzhen, China.
  • The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Shenzhen Longhua Institute of Immunology Transformation, Shenzhen, China.
  • The Seven Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.

ORCID-Profile: Jinwei Li, Xianghui Wen, Jiaoshi Zhao, Xubin Hao, Xiqing Luo, Yiman Fu

Förderung

  • the Shenzhen Longhua District Science and Technology Innovation Special Fund Project
  • the Shenzhen Longhua District Science and Technology Innovation Special Fund Project, Digital Immunity Project
  • the Autonomous Region Key Research and Development (Major) Project

Zitieren

APA

Li, J., Wen, X., Zhao, J., Gao, M., Hao, X., Wen, S., Zhou, L., Wu, X., Luo, X., Cao, S., Wei, Q., Liu, B., Fu, Y., Lv, Q., & Gu, J. (2026). Human Umbilical Cord Mesenchymal Stem Cells Alleviate Autoimmune POI Associated With Downregulated UBE2N ‐Mediated Ovarian Inflammation. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70822

Vancouver

Li J, Wen X, Zhao J, Gao M, Hao X, Wen S, et al. Human Umbilical Cord Mesenchymal Stem Cells Alleviate Autoimmune POI Associated With Downregulated UBE2N ‐Mediated Ovarian Inflammation. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70822

BibTeX
@article{Li2026,
  author = {Li, Jinwei and Wen, Xianghui and Zhao, Jiaoshi and Gao, Min and Hao, Xubin and Wen, Shenghui and Zhou, Liuzhong and Wu, Xinyu and Luo, Xiqing and Cao, Shuangyan and Wei, Qiujing and Liu, Budian and Fu, Yiman and Lv, Qing and Gu, Jieruo},
  title = {Human Umbilical Cord Mesenchymal Stem Cells Alleviate Autoimmune POI Associated With Downregulated UBE2N ‐Mediated Ovarian Inflammation},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  doi = {10.1111/1756-185x.70822}
}
Kostenlos starten →